You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Prescription profile and safety of oral capecitabine in metastatic colorectal cancer patients
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-HPS-025
- By: FERNáNDEZ BARRANTES, Cristina (Caja Costarricense de Seguro Social/ Hospital San Juan de Dios, Drug Information Center, San José, Costa Rica)
- Co-author(s): Angelina Zumbado Arroyo:Pharmacy Service,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica|Cristina Fernández Barrantes:Drug Information Center,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica
- Abstract:
Capecitabine is an oral fluoropyrimidine effective in the treatment of metastatic colorectal cancer, has a toxicity profile well established. The most common adverse reactions reported are hand-foot syndrome, diarrhea, stomatitis, nausea and vomiting. Capecitabine is generally considered well tolerated.
Observacional retrospective study, based on a
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026